Takeda pulls Danish paracetamol batch after two packs found to contain ibuprofen

By Gareth Macdonald contact

- Last updated on GMT


Related tags: Paracetamol, Ibuprofen

Takada Pharma A/S has recalled a batch of its Pamol paracetamol tablets in Denmark after two packs were found to contain ibuprofen.

The Japanese firm announced it was withdrawing the pain killer - batch number 11255945 – last Thursday (here​ in Danish), explaining the move was prompted by the discovery of “non-paracetamol’ tablets were found in two containers.

Takeda also said it had notified all distributors and has launched an investigation into the incident.

The firm did not respond to a request for more information.   


The Danish Medicines Agency (DKMA) warned patients (here​ in Danish) not to take the medicines.

It confirmed that tests had identified the unknown pills as the non-steroidal anti-inflammatory ibuprofen​, which Takeda sells as Ibumetin.

The regulator said: "You should not take any of the tablets, if you have one of the containers from that batch​" advising patients to retun the products.


A spokeswoman for the Japanese firm told us that the recallede batch was not produced by a third party manufacturer.

"Investigations into the incident are still ongoing. The recalled batch was produced by Takeda​" she said.


The headline has been revised to clarify that the ibuprofen was not found by patients.

Related topics: Markets & Regulations, QA/QC, Regulations

Related news

Show more

Related products

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

Related suppliers

Follow us


View more